Danish Scientists Challenge Decades of Vaccine Research

A new analysis from Denmark has questioned the work of two well-known vaccine researchers, Peter Aaby and Christine Stabell Benn, finding that they may have drawn bigger conclusions from their data than the evidence actually supported. The critique, led by Henrik Støvring from Aarhus University, is significant because it examines all of the randomized trials—carefully controlled studies—conducted by Aaby and Benn over nearly 30 years.

Aaby and Benn have spent decades studying vaccines in Guinea-Bissau, a country in West Africa, and more recently in Denmark. Their main theory is that certain vaccines, like measles and tuberculosis shots, do more than just protect against those specific diseases. They claim these vaccines also strengthen the immune system in broader ways that improve children's overall health and survival.

What the Researchers Claimed

Since the late 1970s, Aaby has run the Bandim Health Project in Guinea-Bissau. Benn joined him in the 1990s. Together, they studied thousands of children, running randomized trials to test their ideas about how vaccines might have what they call "non-specific effects"—benefits that go beyond protecting against a single disease.

Wired has reported on their work, noting they believe measles and tuberculosis vaccines strengthen overall health in ways science had not fully recognized. Their publications have been influential. According to ResearchGate, Aaby has authored 221 research papers cited more than 6,000 times. Benn has extended this research to Denmark itself, testing whether the same patterns hold in a wealthier country.

The New Critique

The critique from Aarhus University presents a different picture. Aarhus University reported that Støvring's analysis found that Aaby and Benn had over-interpreted their data—that is, they drew conclusions that were stronger than what the actual numbers showed. This is the first time someone has systematically reviewed all of their trials side by side.

Similar disputes have surfaced in medical research before. When researchers work in difficult field conditions—where it is hard to control all the variables—they sometimes find patterns that look significant, but later scrutiny by independent teams suggests those patterns were not as clear-cut as they first appeared. This happened during the early days of HIV research in the 1990s and again with some debates about COVID-19 vaccine effectiveness.

The broader context here matters. When you study thousands of children over decades, and when you are hoping to find evidence that a health intervention works, it becomes easy to emphasize results that support your theory while downplaying results that do not. Peer reviewers who evaluate papers for publication sometimes miss these patterns, especially when a research team has built a strong reputation over time.

Why This Matters

The questions raised by Støvring's analysis go beyond just one research team. They touch on how science works in global health—a field where researchers often work with vulnerable populations in countries with limited resources. In these settings, there is real pressure to find interventions that help. But that same pressure can lead researchers to overstate what their data shows.

The work conducted by Aaby and Benn took place across very different contexts: a developing country where disease patterns and healthcare have changed dramatically over 40 years, and a wealthy Scandinavian country. Both settings offer real data, but comparing them and drawing firm conclusions requires careful statistical work—work that Støvring's analysis suggests may not have been careful enough.

Non-specific vaccine effects are, in fact, a real phenomenon that immunologists study. The immune system does not work like a simple on-off switch. A vaccine can affect how the immune system behaves more broadly, not just against one disease. But measuring these effects with precision in real-world conditions is genuinely difficult. Dozens of other factors—nutrition, other infections, earlier vaccinations—all play a role.

What Happens Now

The scientific community now has to decide what to do with three decades of published research that may not hold up to scrutiny. Independent researchers will likely try to replicate the original studies. Others may refine the methods to study these questions more carefully. And any health programs that were based on Aaby and Benn's conclusions may need to be reconsidered.

This controversy points to something broader about how science progresses. Today, researchers can analyze large collections of studies quickly and spot patterns that single teams might miss—a capability that simply did not exist when Aaby and Benn began their work in the 1970s. As tools in immunology and genetics improve, scientists will be able to test theories about how vaccines affect the immune system in ways that were impossible before.

The real lesson is straightforward: even respected researchers working in good faith can draw conclusions that do not hold up. That is why peer review, independent replication, and systematic checking of large research portfolios matter so much. The system is designed to catch these things—and in this case, it did.